Corix Bioscience

Corix Bioscience DSCR

The Debt Service Coverage Ratio (DSCR) of Corix Bioscience (CXBS) as of Nov 5, 2026 is -0.36. In the previous year, Debt Service Coverage Ratio (DSCR) was -0.59 — a change of -37.95% (higher).

DSCR

-0.36

YoY

-37.95%

Last updated:

Debt Service Coverage Ratio (DSCR) of Corix Bioscience is 2016 -0.36 . Debt Service Coverage Ratio (DSCR) of Corix Bioscience was 2015 -0.59 . It decreases by -37.95% higher compared to the previous year.

The Corix Bioscience DSCR history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

DSCR
Date
DSCR
Jan 1, 2015
-0.59 USD
Jan 1, 2016
-0.36 USD
The Corix Bioscience DSCR history
YEARDSCRYoY
-0.36-37.95%
-0.59—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corix Bioscience Stock analysis

What does Corix Bioscience do? Corix Bioscience is a company specialized in the production of cannabinoid-based products. It was founded in 2014 under the name American Housing Income Trust, a holding company focused on the American real estate market. In 2017, the company decided to restructure and change its name to Corix Bioscience. Since then, the company has become one of the leading manufacturers of CBD oils and other cannabinoid-based products. Corix Bioscience's business model is based on state-of-the-art technologies and innovation in the cannabinoid industry. The company collaborates with other firms to develop new products tailored to patient needs. The company aims to provide patients with a natural and safe alternative to conventional medical therapy. Corix Bioscience has five divisions. These include "Corix Bioscience," which focuses on the development of CBD-based products for the European market. "Corix Health" develops cannabinoid-based products specifically tailored to patient needs. "Subsidiaries" is responsible for collaborating with other companies to expand the product offering. "Licensing" offers licenses for technologies and rights to use innovative products. "Research and Development" focuses on advancing research and technologies in the cannabinoid industry. One of Corix Bioscience's most well-known products is CBD oil. It is extracted from specially bred hemp plants and is used for pain relief, anxiety, and other ailments. The company also offers CBD-based cosmetic products and food. Corix Bioscience is headquartered in Fresno, California, and is now internationally active. The company places special emphasis on the quality of its products and uses only natural and certified ingredients. Corix Bioscience advocates for fair and sustainable production and focuses on environmental protection and sustainability. The future prospects for Corix Bioscience are promising. The company operates in a forward-thinking market, focusing on innovation and sustainability. The developments in the market for cannabinoid-based products allow Corix Bioscience to expand its portfolio and offer more patients a natural alternative to conventional medical therapy. Corix Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corix Bioscience stock

Debt Service Coverage Ratio (DSCR) of Corix Bioscience is -0.36 in 2016.

Debt Service Coverage Ratio (DSCR) of Corix Bioscience changed from -0.59 to -0.36, representing a -37.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Service Coverage Ratio (DSCR) Corix Bioscience since 2006 – with annual values, charts, and detailed analysis.

The DSCR measures a company's ability to service its debt obligations from operating income. A ratio above 1.0 indicates sufficient income to cover debt payments.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt Service Coverage Ratio (DSCR)'s Corix Bioscience with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Corix Bioscience

All Key Metrics — Corix Bioscience